{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:57:13Z","timestamp":1773997033368,"version":"3.50.1"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00435","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:15:16Z","timestamp":1591341316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of Altered Metabolic Microenvironment in Osteolytic Metastasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Kerstin","family":"Tiedemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana V.","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-013-2799-0","article-title":"Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.","volume":"143","author":"Abdelaziz","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-015-3517-x","article-title":"Localized experimental bone metastasis drives osteolysis and sensory hypersensitivity at distant non-tumor-bearing sites.","volume":"153","author":"Abdelaziz","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/CCO.0b013e328356da72","article-title":"Glucose transporters in cancer metabolism.","volume":"24","author":"Adekola","year":"2012","journal-title":"Curr. Opin. Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153886","article-title":"Accelerated lactate dehydrogenase activity potentiates osteoclastogenesis via NFATc1 signaling.","volume":"11","author":"Ahn","year":"2016","journal-title":"PLoS One"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002104","article-title":"Complex dynamics of osteoclast formation and death in long-term cultures.","volume":"3","author":"Akchurin","year":"2008","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00004","article-title":"Hypoxia-modified cancer cell metabolism.","volume":"7","author":"Al Tameemi","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.abb.2010.07.021","article-title":"Acidosis, hypoxia and bone.","volume":"503","author":"Arnett","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bone.2017.12.021","article-title":"Metabolic properties of the osteoclast.","volume":"115","author":"Arnett","year":"2018","journal-title":"Bone"},{"key":"B9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2165\/00003495-200767030-00004","article-title":"Use of sirolimus in solid organ transplantation.","volume":"67","author":"Augustine","year":"2007","journal-title":"Drugs"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/1535-7163.mct-14-0451","article-title":"Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.","volume":"13","author":"Babcook","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3047.e4","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells.","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/jcb.20842","article-title":"Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways.","volume":"99","author":"Botolin","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0885-7","article-title":"Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.","volume":"19","author":"Browne","year":"2017","journal-title":"Breast Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bone.2018.06.014","article-title":"Bone and plasma citrate is reduced in osteoporosis.","volume":"114","author":"Chen","year":"2018","journal-title":"Bone"},{"key":"B15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver\u2019s seat.","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/annonc\/mdw410","article-title":"Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.","volume":"27","author":"Coyle","year":"2016","journal-title":"Ann. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/15384101.2017.1310353","article-title":"Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab.","volume":"16","author":"Cuy\u00e0s","year":"2017","journal-title":"Cell Cycle"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1002\/pmic.200402059","article-title":"Comparative study of protein and mRNA expression during osteoclastogenesis.","volume":"5","author":"Czupalla","year":"2005","journal-title":"Proteomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1074\/jbc.M116.764761","article-title":"Inactivation of regulatory-associated Protein of mTOR (Raptor)\/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice.","volume":"292","author":"Dai","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/pcan.2011.70","article-title":"Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.","volume":"15","author":"Dittrich","year":"2012","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/jci69741","article-title":"Targeting lactate metabolism for cancer therapeutics.","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","article-title":"Oxidative stress in bone remodeling: role of antioxidants.","volume":"14","author":"Domazetovic","year":"2017","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1083\/jcb.11.3.627","article-title":"The fine structure of bone cells.","volume":"11","author":"Dudley","year":"1961","journal-title":"J. Biophys. Biochem. Cytol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the warburg effect and suppresses tumor growth in vivo.","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2014.01.018","article-title":"The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.","author":"Faubert","year":"2015","journal-title":"Cancer Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.","volume":"15","author":"Fernandez","year":"2001","journal-title":"Genes Dev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.arr.2009.03.003","article-title":"The coordination of nuclear and mitochondrial communication during aging and calorie restriction.","volume":"8","author":"Finley","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1242\/bio.20133269","article-title":"Moderate excess of pyruvate augments osteoclastogenesis.","volume":"2","author":"Fong","year":"2013","journal-title":"Biol. Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.4161\/cc.8.7.8044","article-title":"Targeting mTOR with rapamycin: one dose does not fit all.","volume":"8","author":"Foster","year":"2009","journal-title":"Cell Cycle"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083832","article-title":"Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.","volume":"8","author":"Garofalo","year":"2013","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.molcel.2015.04.031","article-title":"Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2.","volume":"58","author":"Gaubitz","year":"2015","journal-title":"Mol. Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase.","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death. Differ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11080","DOI":"10.1073\/pnas.97.20.11080","article-title":"High phosphorylation efficiency and depression of uncoupled respiration in mitochondria under hypoxia.","volume":"97","author":"Gnaiger","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jnci\/djt026","article-title":"Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.","volume":"105","author":"Gnant","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181230","article-title":"Potassium citrate prevents increased osteoclastogenesis resulting from acidic conditions: implication for the treatment of postmenopausal bone loss.","volume":"12","author":"Granchi","year":"2017","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint.","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family\u2013Structure and functional characterization.","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3922-0","article-title":"Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.","volume":"18","author":"Hernandez","year":"2018","journal-title":"BMC Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1096\/fj.13-233106","article-title":"TDAG8 activation inhibits osteoclastic bone resorption.","volume":"28","author":"Hikiji","year":"2014","journal-title":"FASEB J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.job.2019.02.002","article-title":"Bone metastasis: interaction between cancer cells and bone microenvironment.","volume":"61","author":"Hiraga","year":"2019","journal-title":"J. Oral. Biosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jcb.25287","article-title":"Lysosomal pH plays a key role in regulation of mtor activity in osteoclasts.","volume":"117","author":"Hu","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.188332","article-title":"Targeting citrate as a novel therapeutic strategy in cancer treatment.","volume":"1873","author":"Huang","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2011.09.026","article-title":"Rapamycin inhibits osteolysis and improves survival in a model of experimental bone metastases.","volume":"314","author":"Hussein","year":"2012","journal-title":"Cancer Lett."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52128-2","article-title":"Roles of monocarboxylate transporter subtypes in promotion and suppression of osteoclast differentiation and survival on bone.","volume":"9","author":"Imai","year":"2019","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/jbmr.1976","article-title":"Metabolic regulation of osteoclast differentiation and function.","volume":"28","author":"Indo","year":"2013","journal-title":"J. Bone. Miner. Res."},{"key":"B46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival.","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nm.1910","article-title":"Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation.","volume":"15","author":"Ishii","year":"2009","journal-title":"Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bbrc.2005.09.054","article-title":"Identification of acid-sensing ion channels in bone.","volume":"337","author":"Jahr","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/cpt.418","article-title":"Monocarboxylate transporters: therapeutic targets and prognostic factors in disease.","volume":"100","author":"Jones","year":"2016","journal-title":"Clin. Pharmacol. Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"12187","DOI":"10.1074\/jbc.M112.430389","article-title":"Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice.","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bone.2009.07.010","article-title":"The relationship between calcium accumulation in osteoclast mitochondrial granules and bone resorption.","volume":"45","author":"Kawahara","year":"2009","journal-title":"Bone"},{"key":"B52","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.bone.2008.12.012","article-title":"Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis.","volume":"44","author":"Kawashima","year":"2009","journal-title":"Bone"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2640342","article-title":"mTOR inhibitor therapy and metabolic consequences: where do we stand?","volume":"2018","author":"Kezic","year":"2018","journal-title":"Oxid Med. Cell Longev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1016\/j.febslet.2006.09.015","article-title":"Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts.","volume":"580","author":"Kim","year":"2006","journal-title":"FEBS Lett."},{"key":"B55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1159\/000110454","article-title":"Osteoclast precursors display dynamic metabolic shifts toward accelerated glucose metabolism at an early stage of RANKL-stimulated osteoclast differentiation.","volume":"20","author":"Kim","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/hp.s95960","article-title":"Hypoxic regulation of osteoclast differentiation and bone resorption activity.","volume":"3","author":"Knowles","year":"2015","journal-title":"Hypoxia"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1073\/pnas.0406874102","article-title":"Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium\/calcineurin\/NFAT pathway in osteoclasts.","volume":"102","author":"Komarova","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1242\/bio.20148128","article-title":"Autocrine signaling is a key regulatory element during osteoclastogenesis.","volume":"3","author":"Kopesky","year":"2014","journal-title":"Biol. Open"},{"key":"B59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jcb.10252","article-title":"Glucose-dependent regulation of osteoclast H(+)-ATPase expression: potential role of p38 MAP-kinase.","volume":"87","author":"Larsen","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1139\/o05-136","article-title":"Glucose is a key metabolic regulator of osteoclasts; glucose stimulated increases in ATP\/ADP ratio and calmodulin kinase II activity.","volume":"83","author":"Larsen","year":"2005","journal-title":"Biochem. Cell Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.bone.2009.11.021","article-title":"Ascorbic acid accelerates osteoclast formation and death.","volume":"46","author":"Le Nihouannen","year":"2010","journal-title":"Bone"},{"key":"B62","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.bone.2010.08.001","article-title":"AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts.","volume":"47","author":"Lee","year":"2010","journal-title":"Bone"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1016\/j.bbadis.2017.08.030","article-title":"MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases.","volume":"1863","author":"Lemma","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biocel.2016.08.034","article-title":"Energy metabolism in osteoclast formation and activity.","volume":"79","author":"Lemma","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005705","article-title":"Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1.","volume":"4","author":"Li","year":"2009","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1016\/j.febslet.2013.08.017","article-title":"Acid-sensing ion channel 1a is involved in acid-induced osteoclastogenesis by regulating activation of the transcription factor NFATc1.","volume":"587","author":"Li","year":"2013","journal-title":"FEBS Lett."},{"key":"B67","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bbrc.2018.05.091","article-title":"Monocarboxylate transporters in breast cancer and adipose tissue are novel biomarkers and potential therapeutic targets.","volume":"501","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2009.08.069","article-title":"Artefacts in cell culture: pyruvate as a scavenger of hydrogen peroxide generated by ascorbate or epigallocatechin gallate in cell culture media.","volume":"388","author":"Long","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation.","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00432-013-1518-x","article-title":"Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.","volume":"139","author":"Maass","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s00424-003-1128-6","article-title":"The SLC13 gene family of sodium sulphate\/carboxylate cotransporters.","volume":"447","author":"Markovich","year":"2004","journal-title":"Pflugers. Arch."},{"key":"B73","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/pros.20752","article-title":"RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.","volume":"68","author":"Morgan","year":"2008","journal-title":"Prostate"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1038\/sj.emboj.7601317","article-title":"Secretion of L-glutamate from osteoclasts through transcytosis.","volume":"25","author":"Morimoto","year":"2006","journal-title":"EMBO J."},{"key":"B75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40264-019-00810-9","article-title":"Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation.","volume":"42","author":"Nguyen","year":"2019","journal-title":"Drug Saf."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/0008-5472.Can-13-2645","article-title":"Contributions of the host microenvironment to cancer-induced bone disease.","volume":"74","author":"Olechnowicz","year":"2014","journal-title":"Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00424-013-1369-y","article-title":"Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family.","volume":"466","author":"Pajor","year":"2014","journal-title":"Pflugers. Arch."},{"key":"B78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bone.2007.08.044","article-title":"Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway.","volume":"42","author":"Pereverzev","year":"2008","journal-title":"Bone"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2014.00017","article-title":"An evolutionary perspective on the crabtree effect.","volume":"1","author":"Pfeiffer","year":"2014","journal-title":"Front. Mol. Biosci."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-016-0153-9","article-title":"Fast exchange fluxes around the pyruvate node: a leaky cell model to explain the gain and loss of unlabelled and labelled metabolites in a tracer experiment.","volume":"4","author":"Quek","year":"2016","journal-title":"Cancer Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.canlet.2015.03.012","article-title":"Peroxiredoxin 4: a novel secreted mediator of cancer induced osteoclastogenesis.","volume":"361","author":"Rafiei","year":"2015","journal-title":"Cancer Lett."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078043","article-title":"Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFbeta.","volume":"8","author":"Rana","year":"2013","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1021\/pr200550p","article-title":"Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma.","volume":"10","author":"Rocha","year":"2011","journal-title":"J. Proteome Res."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19102850","article-title":"Pleiotropic effects of metformin on cancer.","volume":"19","author":"Schulten","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1139\/y10-070","article-title":"Extracellular glutamate alters mature osteoclast and osteoblast functions.","volume":"88","author":"Seidlitz","year":"2010","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.bone.2010.04.596","article-title":"AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass.","volume":"47","author":"Shah","year":"2010","journal-title":"Bone"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1717-8","article-title":"Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells.","volume":"15","author":"Simone","year":"2015","journal-title":"BMC Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1084952102000587","article-title":"Formation and function of the ruffled border in osteoclasts.","volume":"13","author":"Stenbeck","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1074\/jbc.M410480200","article-title":"Akt1\/Akt2 and mammalian target of rapamycin\/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors.","volume":"280","author":"Sugatani","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"223s","DOI":"10.3945\/ajcn.113.070086","article-title":"Role of amino acid transporters in amino acid sensing.","volume":"99","author":"Taylor","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2017.00054","article-title":"Regulation of osteoclast growth and fusion by mTOR\/raptor and mTOR\/rictor\/Akt.","volume":"5","author":"Tiedemann","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.tranon.2018.11.014","article-title":"Exosomal release of L-plastin by breast cancer cells facilitates metastatic bone osteolysis.","volume":"12","author":"Tiedemann","year":"2019","journal-title":"Transl. Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.mehy.2013.08.032","article-title":"Inhibitory effect of metformin on bone metastasis of cancer via OPG\/RANKL\/RANK system.","volume":"81","author":"Wang","year":"2013","journal-title":"Med. Hypotheses"},{"key":"B94","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cmet.2010.04.015","article-title":"PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss.","volume":"11","author":"Wei","year":"2010","journal-title":"Cell Metab."},{"key":"B95","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1006\/bbrc.1997.6795","article-title":"Regulation of osteoclastic bone resorption by glucose.","volume":"235","author":"Williams","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.bone.2008.02.006","article-title":"High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.","volume":"42","author":"Wittrant","year":"2008","journal-title":"Bone"},{"key":"B97","doi-asserted-by":"publisher","first-page":"23598","DOI":"10.1074\/jbc.M602191200","article-title":"Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis.","volume":"281","author":"Yang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s12325-013-0060-1","article-title":"Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.","volume":"30","author":"Yardley","year":"2013","journal-title":"Adv. Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1242\/jcs.170738","article-title":"KCNK1 inhibits osteoclastogenesis by blocking the Ca2+ oscillation and JNK-NFATc1 signaling axis.","volume":"128","author":"Yeon","year":"2015","journal-title":"J. Cell Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/abbs\/gmu069","article-title":"Everolimus and zoledronic acid\u2013a potential synergistic treatment for lung adenocarcinoma bone metastasis.","volume":"46","author":"Yu","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00222","article-title":"The roles of acidosis in osteoclast biology.","volume":"7","author":"Yuan","year":"2016","journal-title":"Front. Physiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"22365","DOI":"10.3390\/ijms151222365","article-title":"Molecular actions of ovarian cancer G protein-coupled receptor 1 caused by extracellular acidification in bone.","volume":"15","author":"Yuan","year":"2014","journal-title":"Int. J. Mol. Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/jbmr.2584","article-title":"Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms.","volume":"30","author":"Zeng","year":"2015","journal-title":"J. Bone Mineral Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/jbmr.3398","article-title":"PGC1beta organizes the osteoclast cytoskeleton by mitochondrial biogenesis and activation.","volume":"33","author":"Zhang","year":"2018","journal-title":"J. Bone Mineral Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:15:19Z","timestamp":1591341319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":104,"alternative-id":["10.3389\/fcell.2020.00435"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00435","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"article-number":"435"}}